# Pudendal Block Using Liposomal Bupivacaine vs. Standard Treatment During Sacrospinous Ligament Fixation

> **NCT03664986** · PHASE4 · UNKNOWN · sponsor: **Atlantic Health System** · enrollment: 88 (estimated)

## Conditions studied

- Vaginal Prolapse

## Interventions

- **DRUG:** Liposomal Bupivacaine

## Key facts

- **NCT ID:** NCT03664986
- **Lead sponsor:** Atlantic Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09-24
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2021-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03664986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03664986, "Pudendal Block Using Liposomal Bupivacaine vs. Standard Treatment During Sacrospinous Ligament Fixation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03664986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*